Can Wegovy Cause Bruising at the Injection Site?

Bruising at the injection site is a recognised, non-serious reaction — small capillaries can be nicked by the needle regardless of technique.
The most effective way to reduce bruising is rotating injection sites (abdomen, thigh, outer upper arm) and avoiding the same spot twice in a row.
Semaglutide does not thin the blood, but rapid weight loss can affect how fat tissue sits under the skin, which may change how injections feel over time.
Widespread, spontaneous or worsening bruising anywhere on the body (not just at the needle site) is different and should be discussed with a prescriber or your GP promptly.

Bruising after a Wegovy injection is common and almost always harmless. Semaglutide itself does not damage blood vessels, but the needle puncturing small capillaries just beneath the skin causes the discolouration most people notice. It typically fades within a few days and is rarely a sign of anything serious. That said, there are a handful of situations where bruising or easy bruising on semaglutide warrants a closer look — and those are worth knowing before you start. As a prescription-only medicine, Wegovy is only available after a clinical assessment by a qualified prescriber, who can also advise on technique to reduce injection-site reactions.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the bruising actually means, and when it matters

The misconception: Wegovy must be irritating your blood

The most common assumption people make when they spot a bruise after a Wegovy injection is that the medicine itself is doing something to their blood, thinning it, irritating vessels, or triggering a reaction inside the body. That picture is not accurate. Semaglutide, the active ingredient in Wegovy, is not an anticoagulant and does not affect platelet function or clotting in the way that medicines like aspirin or warfarin do. The bruising is mechanical, not pharmacological.

What actually happens is straightforward. The Wegovy pen delivers semaglutide into subcutaneous tissue, the layer of fat just below the skin. That layer is threaded with tiny capillaries. A needle, however fine, can clip one of them. Blood then spreads into the surrounding tissue and shows up as the familiar purple-to-yellow bruise over the following hours. The same thing happens with flu jabs, insulin pens and any other subcutaneous injection. It has nothing to do with whether Wegovy is working or whether your dose needs adjusting.

For most people, the bruise is small, tender for a day or two, and gone within a week. The NHS semaglutide page lists injection-site reactions (redness, swelling and bruising among them) as common side effects that do not usually require medical attention. If you have specific questions about your own bruising pattern, our Wegovy treatment page has broader information on what to expect during treatment.

Why some people bruise more than others on semaglutide

There is genuine variation between people, and several factors make injection-site bruising more likely regardless of which GLP-1 medicine you are using. Thinner subcutaneous fat means less cushioning between the needle tip and capillaries. Skin that has already been injected recently in the same spot is more likely to have an irritated capillary close to the surface. Injecting cold medicine straight from the fridge (rather than letting the pen sit at room temperature for a few minutes) can cause a slightly sharper initial sting and a small amount of tissue reaction.

Technique matters too. Pinching the skin gently before inserting the needle, inserting at the right angle (the pen is designed to be held perpendicular to the skin), and pressing the injection button smoothly rather than jabbing all reduce the chance of hitting a capillary directly. Releasing the pinch before withdrawing the needle (rather than after) also helps. These are things a prescriber or the Patient Information Leaflet will walk you through; they are worth revisiting if bruising is happening every week.

People who take antiplatelet medicines (low-dose aspirin, clopidogrel) or anticoagulants will bruise more easily from any injection, including Wegovy. If that applies to you, it is worth mentioning at your next clinical review. Our semaglutide overview covers the broader drug-interaction picture, and the question of what to tell your prescriber about other medicines you take.

There is also a subtler factor that some people notice later in treatment: as body composition changes with weight loss, the feel and depth of subcutaneous tissue at familiar injection sites shifts. A site that worked well at the start of treatment may need re-evaluating after a few months.

When bruising from Wegovy is not just about the injection site

A small bruise where the needle went in is expected. Bruising that appears away from any injection site (on your arms, legs or torso) is a different matter, and does not have an obvious mechanical explanation. If you are wondering whether Wegovy causes easy bruising across the body rather than just at injection sites, easy bruising can be a sign of a nutritional deficiency (particularly vitamin C, vitamin K or certain B vitamins), a platelet disorder, or a side effect of another medicine. Rapid weight loss, which Wegovy can produce over several months, occasionally unmasks these issues by changing how the body processes micronutrients.

If you are bruising easily all over and Wegovy is recent, it is worth raising with your GP or prescriber rather than assuming it is treatment-related. For a closer look at bruising related to Wegovy, including when to be concerned and what patterns are considered normal, our dedicated page covers this in more detail. The same applies if a single injection-site bruise is unusually large, painful beyond a couple of days, or accompanied by warmth and spreading redness, that pattern can occasionally indicate a small infection at the site and merits prompt attention.

For context on other unexpected symptoms that sometimes prompt questions (like changes in vision or mood) pages on our site address those specifically. One people ask about less often is whether semaglutide affects vision, which is a separate safety topic worth understanding if it comes up for you.

The MHRA's Yellow Card scheme exists precisely for situations where you are unsure whether a symptom is medicine-related. You can report a suspected side effect at yellowcard.mhra.gov.uk, it takes a few minutes and contributes to ongoing medicine safety monitoring across the UK.

Practical steps to reduce bruising and when to speak to someone

Most people find bruising becomes less frequent once they settle into a consistent injection routine. Rotating between three sites (abdomen (avoiding the two-inch zone around the navel), front or outer thigh, and outer upper arm) gives each area time to recover. Keeping a simple note of which site you used last is enough; it does not need to be elaborate. Some people find pairing injection day with a regular weekly anchor (a Monday morning before work, or the same evening each week) makes rotation easier to track. If your delivery arrives on a Wednesday because you ordered on payday, building the habit around that day works just as well.

Letting the pen warm to room temperature before injecting, checking that the injection site is clean and dry, and using a fresh needle every time are the basics that make the biggest practical difference. If you are on the Wegovy treatment pathway through a regulated service, these points should be part of the aftercare you receive.

Bruising that is severe, unusual in location, or part of a broader pattern of easy bruising is worth a conversation with a clinician. Our aftercare team is available seven days a week, and a clinical review is part of every repeat prescription at nume, so nothing gets waved through without a prescriber looking at the full picture. If you have not yet started treatment and want to understand what the process looks like, you are welcome to start a free consultation and speak to one of our prescribers about what to expect.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions